George Vielhauer

1.7k total citations
33 papers, 1.4k citations indexed

About

George Vielhauer is a scholar working on Molecular Biology, Materials Chemistry and Computational Theory and Mathematics. According to data from OpenAlex, George Vielhauer has authored 33 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 7 papers in Materials Chemistry and 5 papers in Computational Theory and Mathematics. Recurrent topics in George Vielhauer's work include Heat shock proteins research (14 papers), Protein Structure and Dynamics (7 papers) and Enzyme Structure and Function (6 papers). George Vielhauer is often cited by papers focused on Heat shock proteins research (14 papers), Protein Structure and Dynamics (7 papers) and Enzyme Structure and Function (6 papers). George Vielhauer collaborates with scholars based in United States, Japan and Egypt. George Vielhauer's co-authors include Brian S. J. Blagg, Jeffrey M. Holzbeierlein, Alison C. Donnelly, Joseph A. Burlison, Huiping Zhao, Bhaskar Reddy Kusuma, Roger A. Rajewski, Douglas Brown, Laura B. Peterson and John W. Regan and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Blood.

In The Last Decade

George Vielhauer

33 papers receiving 1.4k citations

Peers

George Vielhauer
A.E. Surgenor United Kingdom
Alison Maloney United Kingdom
Haizhen A. Zhong United States
Massimiliano Meli Italy
Guixian Jin United States
Wen‐Cherng Lee United States
Keizo Koya United States
Jean‐Michel Rondeau Switzerland
Bainan Wu United States
Tamer S. Kaoud United States
A.E. Surgenor United Kingdom
George Vielhauer
Citations per year, relative to George Vielhauer George Vielhauer (= 1×) peers A.E. Surgenor

Countries citing papers authored by George Vielhauer

Since Specialization
Citations

This map shows the geographic impact of George Vielhauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George Vielhauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George Vielhauer more than expected).

Fields of papers citing papers by George Vielhauer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George Vielhauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George Vielhauer. The network helps show where George Vielhauer may publish in the future.

Co-authorship network of co-authors of George Vielhauer

This figure shows the co-authorship network connecting the top 25 collaborators of George Vielhauer. A scholar is included among the top collaborators of George Vielhauer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George Vielhauer. George Vielhauer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Weiya, George Vielhauer, Jeffrey M. Holzbeierlein, et al.. (2015). KU675, a Concomitant Heat-Shock Protein Inhibitor of Hsp90 and Hsc70 that Manifests Isoform Selectivity for Hsp90α in Prostate Cancer Cells. Molecular Pharmacology. 88(1). 121–130. 33 indexed citations
2.
Zeineldin, Maged, et al.. (2014). Human Cancer Xenografts in Outbred Nude Mice Can Be Confounded by Polymorphisms in a Modifier of Tumorigenesis. Genetics. 197(4). 1365–1376. 5 indexed citations
3.
Ghosh, Suman, Heather Shinogle, Gaurav Garg, et al.. (2014). Hsp90 C-Terminal Inhibitors Exhibit Antimigratory Activity by Disrupting the Hsp90α/Aha1 Complex in PC3-MM2 Cells. ACS Chemical Biology. 10(2). 577–590. 34 indexed citations
4.
Paul, Arindam, Sumedha Gunewardena, Shane R. Stecklein, et al.. (2014). PKCλ/ι signaling promotes triple-negative breast cancer growth and metastasis. Cell Death and Differentiation. 21(9). 1469–1481. 39 indexed citations
5.
Brown, Douglas, Huiping Zhao, Bhaskar Reddy Kusuma, et al.. (2013). Development of a High-Throughput Screening Cancer Cell-Based Luciferase Refolding Assay for Identifying Hsp90 Inhibitors. Assay and Drug Development Technologies. 11(8). 478–488. 12 indexed citations
6.
Garimella, Rama Murthy, George Vielhauer, Hong Yan, et al.. (2013). Biological characterization of preclinical Bioluminescent Osteosarcoma Orthotopic Mouse (BOOM) model: A multi-modality approach. Journal of bone oncology. 2(1). 11–21. 19 indexed citations
7.
Vielhauer, George, et al.. (2013). Evaluation of a reductively activated duocarmycin prodrug against murine and human solid cancers. Cancer Biology & Therapy. 14(6). 527–536. 8 indexed citations
8.
Wolfe, Amanda L., Katharine K. Duncan, Nikhil K. Parelkar, et al.. (2013). Efficacious Cyclic N-Acyl O-Amino Phenol Duocarmycin Prodrugs. Journal of Medicinal Chemistry. 56(10). 4104–4115. 14 indexed citations
9.
Aljitawi, Omar S., Nikhil K. Parelkar, Jeff Radel, et al.. (2013). Hyperbaric oxygen improves engraftment of ex-vivo expanded and gene transduced human CD34+ cells in a murine model of umbilical cord blood transplantation. Blood Cells Molecules and Diseases. 52(1). 59–67. 14 indexed citations
10.
Peterson, Laura B., et al.. (2012). The hERG Channel Is Dependent upon the Hsp90α Isoform for Maturation and Trafficking. Molecular Pharmaceutics. 9(6). 1841–1846. 56 indexed citations
11.
Morales, Pedro Jorge Cortes, Xiaoying Zhang, Stacey L. Hembruff, et al.. (2011). Development and characterization of a novel C-terminal inhibitor of Hsp90 in androgen dependent and independent prostate cancer cells. BMC Cancer. 11(1). 468–468. 75 indexed citations
12.
Nirmalanandhan, Victor S., et al.. (2010). Activity of Anticancer Agents in a Three-Dimensional Cell Culture Model. Assay and Drug Development Technologies. 8(5). 581–590. 63 indexed citations
13.
Vielhauer, George, et al.. (2010). Expression of the C-C Chemokine Receptor 7 Mediates Metastasis of Breast Cancer to the Lymph Nodes in Mice. Translational Oncology. 3(6). 354–361. 71 indexed citations
14.
Holzbeierlein, Jeffrey M., et al.. (2010). Hsp90: A Drug Target?. Current Oncology Reports. 12(2). 95–101. 71 indexed citations
15.
Matthews, Shawna B., George Vielhauer, Robert L. Matts, et al.. (2009). Characterization of a novel novobiocin analogue as a putative C‐terminal inhibitor of heat shock protein 90 in prostate cancer cells. The Prostate. 70(1). 27–36. 40 indexed citations
16.
Shelton, Shary N., Shawna B. Matthews, Yuanming Lu, et al.. (2009). KU135, a Novel Novobiocin-Derived C-Terminal Inhibitor of the 90-kDa Heat Shock Protein, Exerts Potent Antiproliferative Effects in Human Leukemic Cells. Molecular Pharmacology. 76(6). 1314–1322. 83 indexed citations
17.
Vielhauer, George, et al.. (2006). Eukaryotic initiation factor 4E variants alter the morphology, proliferation, and colony‐formation properties of MDA‐MB‐435 cancer cells. Molecular Carcinogenesis. 46(1). 71–84. 6 indexed citations
18.
Fujino, Hiromichi, George Vielhauer, & John W. Regan. (2004). Prostaglandin E2 Selectively Antagonizes Prostaglandin F2α-stimulated T-cell Factor/β-Catenin Signaling Pathway by the FPB Prostanoid Receptor. Journal of Biological Chemistry. 279(42). 43386–43391. 9 indexed citations
19.
Weber, Thomas J., Lye Meng Markillie, William Chrisler, George Vielhauer, & John W. Regan. (2002). Modulation of JB6 mouse epidermal cell transformation response by the prostaglandin F2α receptor. Molecular Carcinogenesis. 35(4). 163–172. 8 indexed citations
20.
Unger, Evan C., et al.. (1998). MRX 501: A novel ultrasound contrast agent with therapeutic properties. Academic Radiology. 5. S247–S249. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A.E. Surgenor Breakdown of academic impact, for papers by Alison Maloney Breakdown of academic impact, for papers by Haizhen A. Zhong Breakdown of academic impact, for papers by Massimiliano Meli Breakdown of academic impact, for papers by Guixian Jin Breakdown of academic impact, for papers by Wen‐Cherng Lee Breakdown of academic impact, for papers by Keizo Koya Breakdown of academic impact, for papers by Jean‐Michel Rondeau Breakdown of academic impact, for papers by Bainan Wu Breakdown of academic impact, for papers by Tamer S. Kaoud
Rankless by CCL
2026